CELFULL to debut Celfavor delivery tech at Vitafoods Europe 2026

By AI, Created 9:49 AM UTC, May 20, 2026, /AGP/ – CELFULL will unveil its patented Celfavor controlled-release microspheres at Vitafoods Europe 2026 in Barcelona, positioning the technology as a way to improve stability, taste and absorption in anti-aging supplements. The launch reflects a broader shift in nutraceuticals from packing in more ingredients to improving how active compounds are delivered.

Why it matters: - CELFULL is trying to move supplement competition away from ingredient count and toward delivery technology. - The company’s Celfavor® platform is designed to protect sensitive anti-aging ingredients from degradation, improve absorption and reduce taste problems. - Better delivery can affect whether consumers get usable doses from products marketed for cellular health and aging support.

What happened: - CELFULL announced it is launching its Celfavor® series of advanced aging intervention preparation solutions at Vitafoods Europe 2026. - The launch is taking place at the Fira Barcelona Gran Via exhibition center in Barcelona from May 5 to May 7, 2026. - The announcement centers on Celfavor® patented controlled-release microspheres.

The details: - CELFULL says the technology uses a multi-core structure and soluble wall materials to create full-chain protection for active ingredients. - The system is designed to preserve ingredient activity during storage. - The formulation is built to resist acid in the stomach. - The technology is intended to release ingredients in the intestines for sustained absorption. - CELFULL says the microspheres help mask bitter taste and metallic odor. - The platform is built for multi-ingredient formulas because different actives are encapsulated relatively independently. - CELFULL says the approach improves compatibility among ingredients without increasing dosage. - The technology is already in a mature “Celfavor® + Active Substances” model. - Current applications include NADH, reduced Coenzyme Q10, NMNH, PQQ and ergothioneine. - Brandon White, Senior R&D Director at CELFULL, said the challenge is getting anti-aging molecules to the cells that need them. - White said Celfavor® is meant to improve stability and absorption and support cellular health.

Between the lines: - The launch reflects an industry push to prove that formulation quality matters as much as raw ingredient selection. - The emphasis on stability, release timing and taste suggests brands are competing on user experience as well as efficacy claims. - CELFULL is framing delivery science as the bridge between research-stage compounds and consumer products.

What’s next: - CELFULL will use Vitafoods Europe 2026 to introduce the Celfavor® platform to the global nutraceutical market. - The company is likely to expand applications of the delivery system across additional anti-aging and functional ingredients. - The market will be watching whether delivery-focused formulations become a stronger selling point for supplements aimed at longevity and cellular health.

The bottom line: - CELFULL is betting that better delivery, not bigger dosages, will define the next round of anti-aging supplement competition.